Incyte Statistics
Total Valuation
Incyte has a market cap or net worth of $18.27 billion. The enterprise value is $14.79 billion.
| Market Cap | 18.27B |
| Enterprise Value | 14.79B |
Important Dates
The next estimated earnings date is Tuesday, April 28, 2026, before market open.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Incyte has 199.01 million shares outstanding. The number of shares has decreased by -4.67% in one year.
| Current Share Class | 199.01M |
| Shares Outstanding | 199.01M |
| Shares Change (YoY) | -4.67% |
| Shares Change (QoQ) | +1.66% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | 87.74% |
| Float | 166.88M |
Valuation Ratios
The trailing PE ratio is 14.29 and the forward PE ratio is 12.35. Incyte's PEG ratio is 0.08.
| PE Ratio | 14.29 |
| Forward PE | 12.35 |
| PS Ratio | 3.56 |
| Forward PS | 3.22 |
| PB Ratio | 3.53 |
| P/TBV Ratio | 3.72 |
| P/FCF Ratio | 13.52 |
| P/OCF Ratio | 12.96 |
| PEG Ratio | 0.08 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.27, with an EV/FCF ratio of 10.92.
| EV / Earnings | 11.49 |
| EV / Sales | 2.88 |
| EV / EBITDA | 10.27 |
| EV / EBIT | 10.98 |
| EV / FCF | 10.92 |
Financial Position
The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.32 |
| Quick Ratio | 3.04 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.04 |
| Interest Coverage | 554.57 |
Financial Efficiency
Return on equity (ROE) is 29.87% and return on invested capital (ROIC) is 61.15%.
| Return on Equity (ROE) | 29.87% |
| Return on Assets (ROA) | 13.57% |
| Return on Invested Capital (ROIC) | 61.15% |
| Return on Capital Employed (ROCE) | 24.74% |
| Weighted Average Cost of Capital (WACC) | 8.88% |
| Revenue Per Employee | $1.81M |
| Profits Per Employee | $452,409 |
| Employee Count | 2,844 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 30.29 |
Taxes
In the past 12 months, Incyte has paid $377.80 million in taxes.
| Income Tax | 377.80M |
| Effective Tax Rate | 22.70% |
Stock Price Statistics
The stock price has increased by +34.93% in the last 52 weeks. The beta is 0.84, so Incyte's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +34.93% |
| 50-Day Moving Average | 101.62 |
| 200-Day Moving Average | 88.99 |
| Relative Strength Index (RSI) | 30.16 |
| Average Volume (20 Days) | 1,568,102 |
Short Selling Information
The latest short interest is 11.01 million, so 5.53% of the outstanding shares have been sold short.
| Short Interest | 11.01M |
| Short Previous Month | 11.01M |
| Short % of Shares Out | 5.53% |
| Short % of Float | 6.60% |
| Short Ratio (days to cover) | 5.68 |
Income Statement
In the last 12 months, Incyte had revenue of $5.14 billion and earned $1.29 billion in profits. Earnings per share was $6.41.
| Revenue | 5.14B |
| Gross Profit | 2.72B |
| Operating Income | 1.35B |
| Pretax Income | 1.66B |
| Net Income | 1.29B |
| EBITDA | 1.44B |
| EBIT | 1.35B |
| Earnings Per Share (EPS) | $6.41 |
Balance Sheet
The company has $3.58 billion in cash and $54.92 million in debt, with a net cash position of $3.53 billion or $17.72 per share.
| Cash & Cash Equivalents | 3.58B |
| Total Debt | 54.92M |
| Net Cash | 3.53B |
| Net Cash Per Share | $17.72 |
| Equity (Book Value) | 5.17B |
| Book Value Per Share | 26.04 |
| Working Capital | 3.51B |
Cash Flow
In the last 12 months, operating cash flow was $1.41 billion and capital expenditures -$58.87 million, giving a free cash flow of $1.35 billion.
| Operating Cash Flow | 1.41B |
| Capital Expenditures | -58.87M |
| Free Cash Flow | 1.35B |
| FCF Per Share | $6.81 |
Margins
Gross margin is 52.89%, with operating and profit margins of 26.19% and 25.03%.
| Gross Margin | 52.89% |
| Operating Margin | 26.19% |
| Pretax Margin | 32.37% |
| Profit Margin | 25.03% |
| EBITDA Margin | 28.00% |
| EBIT Margin | 26.19% |
| FCF Margin | 26.35% |
Dividends & Yields
Incyte does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.67% |
| Shareholder Yield | 4.67% |
| Earnings Yield | 7.03% |
| FCF Yield | 7.40% |
Analyst Forecast
The average price target for Incyte is $101.10, which is 10.16% higher than the current price. The consensus rating is "Buy".
| Price Target | $101.10 |
| Price Target Difference | 10.16% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (5Y) | -1.08% |
| EPS Growth Forecast (5Y) | -7.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 1, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 1, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Incyte has an Altman Z-Score of 7.08 and a Piotroski F-Score of 7.
| Altman Z-Score | 7.08 |
| Piotroski F-Score | 7 |